Skip to main content
logo
Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
12.75
-0.08 (-0.62%)
At close: Oct 30, 2026, 4:00 PM EDT
12.50
-0.25 (-1.96%)
After-hours: Oct 30, 2026, 7:30 PM EDT

IART Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6571,6351,6111,5421,5581,542
Revenue Growth
0.84%1.54%4.47%-1.03%0.99%12.43%
Gross Profit
919.84919.42959.12884.74970.31944.64
Operating Income
163.76145.92181.98111.53238.92199.98
Net Income
13.01-516.47-6.9467.74180.55169.08
Earnings Per Share
0.17-6.74-0.090.842.161.98
EPS Growth
----61.11%9.09%26.11%

Revenue by Segment
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Specialty Surgery
1,2201,2011,1441,0591,0201,025
Tissue Reconstruction
436.95434.73466.89482.58538.1517.22
Total
1,6571,6351,6111,5421,5581,542

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
311.93263.74273.57309.1456.66513.45
Total Debt
2,0032,0351,9861,6841,6151,700
Net Cash (Debt)
-1,691-1,771-1,713-1,374-1,159-1,186
Net Cash Growth
------
Net Cash Per Share
-21.78-23.10-22.24-17.11-13.87-13.88

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
140.450.38129.38139.96264.47312.43
Capital Expenditures
-54.62-81.44-104.42-66.87-42.34-48.02
Free Cash Flow
85.78-31.0524.9673.09222.13264.41
Free Cash Flow Growth
---65.84%-67.09%-15.99%60.30%

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
55.52%56.23%59.55%57.39%62.29%61.24%
Operating Margin
9.88%8.92%11.30%7.23%15.34%12.96%
Pretax Margin
1.35%-34.46%-1.13%5.26%13.73%13.92%
Profit Margin
0.78%-31.58%-0.43%4.39%11.59%10.96%
FCF Margin
5.18%-1.90%1.55%4.74%14.26%17.14%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
75.92--50.2625.9433.56
Forward PE
5.475.218.8312.9416.1620.19
P/FCF Ratio
11.56-70.1046.5821.0821.46
PS Ratio
0.600.591.092.213.013.68